J-SKI will be able to elucidate whether the renal function recover or not after discontinuation of tyrosine kinase inhibitors

Int J Hematol. 2020 Sep;112(3):429-430. doi: 10.1007/s12185-020-02945-3. Epub 2020 Jul 12.

Sho Okamoto¹, Hiroshi Ureshino^{2

3}, Shinya Kimura^{1

4}

¹ Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
² Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan. sr0795@cc-saga-u.ac.jp.
³ Department of Drug Discovery and Biomedical Sciences, Saga University, Saga, Japan. sr0795@cc-saga-u.ac.jp.
⁴ Department of Drug Discovery and Biomedical Sciences, Saga University, Saga, Japan.

No abstract available

Publication types